Gara Jalqabaatti › Neuroblastoma › Massachusetts › Boston
Qorannoo klinikaalii Neuroblastoma Boston, MA keessatti
Qorannoo 13 Neuroblastoma f Boston fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.
Takkalaa qorannoo (Ingiliffa)
Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →
Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma
Namoota walitti qabaa jiraSadarkaa 3
- Massachusetts General Hospital Cancer Center, Boston
- Dana-Farber Cancer Institute, Boston
MCT for the Harvard/UCSF ROBIN Center
Namoota walitti qabaa jira
- Brigham and Women's Hospital, Boston
Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)
Namoota walitti qabaa jiraSadarkaa 1/2
- Dana-Farber Cancer Institute ( Site 1013), Boston
B7-H3.CD28Z.CART in Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1
- Dana Farber Cancer Institite, Boston
Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)
Namoota walitti qabaa jiraSadarkaa 3
- Massachusetts General Hospital Cancer Center, Boston
- Dana-Farber Cancer Institute, Boston
Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
Namoota walitti qabaa jiraSadarkaa 1/2
- Dana-Farber Cancer Institute, Boston
SPEARHEAD-3 Pediatric Study
Namoota walitti qabaa jiraSadarkaa 1/2
- Dana Farber Cancer Institute, Boston
PEEL-224, Vincristine and Temozolomide in Pediatric Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1/2
- Boston Children's Hospital, Boston
- Dana-Farber Cancer Institute, Boston
NANT 2021-01 Phase II STING (Sequential Temozolomide, Irinotecan, NK Cells and GD2 mAb) Trial
Namoota walitti qabaa jiraSadarkaa 2
- Boston Children's Hospital, Dana-Farber Cancer Institute., Boston
Feasibility Study of Prolonged Administration of Naxitamab, Irinotecan, and Temozolomide for Patients With Relapsed or Refractory Neuroblastoma
Namoota walitti qabaa jiraSadarkaa 1
- Boston Children's Hospital, Boston
- Dana-Farber Cancer Institute, Boston
Neuroblastoma Biology Study
Namoota walitti qabaa jiraQorannoo ilaalaa
- Children's Hospital Boston, Boston
Resource Intervention to Support Equity (RISE) in High-Risk Neuroblastoma
Namoota walitti qabaa jira
- Dana-Farber Cancer Institute, Boston
Study of hALK.CAR T Cells for Patients With Relapsed/Refractory High-risk Neuroblastoma
Namoota walitti qabaa jiraSadarkaa 1/2
- Boston Children's Hospital, Boston
- Dana-Farber Cancer Institute, Boston
Qorannoo Neuroblastoma magaalota biroo keessatti
- Washington, DCQorannoo 11
- New York City, NYQorannoo 10
- St. Louis, MOQorannoo 9
- Dallas, TXQorannoo 9
- Memphis, TNQorannoo 9
- Philadelphia, PAQorannoo 9
- Hartford, CTQorannoo 8
- Birmingham, ALQorannoo 8
- Minneapolis, MNQorannoo 8
- Aurora, COQorannoo 8
- Miami, FLQorannoo 7
- Orlando, FLQorannoo 7
Qorannoo biroo Boston keessatti
- Saree OljooQorannoo 112
- Kansara Qara'a Non-Small CellQorannoo 90
- Saree (Gosoota Hunda)Qorannoo 85
- Kansara MetastatikiiQorannoo 63
- Kansarii ColorectalQorannoo 63
- Dhibee QaraQorannoo 62
- Kansarii OvariiQorannoo 61
- Kansarii ProstateQorannoo 59
- DepreshiniiQorannoo 52
- Kansa EndometiriyaaliiQorannoo 50
- Cufama OnneeQorannoo 44
- Leukemia Myeloidii HamaaQorannoo 44
Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.